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CCAAT/enhancer binding protein alpha (C/EBPa) is a transcription factor that inﬂuences immune
cell fate and differentiation. However, the effect of C/EBPa on mast cells is not fully understood.
In this study, we showed that C/EBPa suppressed granule formation in mast cells and increasedmac-
rophage inﬂammatory protein (MIP)-2 production frommast cells upon bacterial stimulation. These
results indicate that C/EBPa regulates the balance between the allergic response and the innate
immune response of mast cells. Furthermore, we showed that stimulation of mast cells with
the Lactobacillus casei JCM1134T strain during late differentiation up-regulated C/EBPa expression
in differentiated mast cells. This suggests that intestinal commensal bacteria modulate C/EBPa
expression and thereby regulate mast cell function.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Transcription factors function as the key regulators of gene
transcription and greatly inﬂuence immune cell fate and differen-
tiation. The differentiation and lineage speciﬁcation of hematopoi-
etic cells are coordinated by both general and lineage-restricted
transcription factors. The expression of lineage-restricted tran-
scription factors is strictly controlled and is critical for promoting
the correct differentiation program.
The basic region-leucine zipper transcription factor CCAAT/
enhancer-binding protein a (C/EBPa) was initially identiﬁed in
the liver and adipose tissue [1,2] where it was shown to be impor-
tant for the terminal differentiation of adipocytes [2,3]. C/EBPa is
also expressed in hematopoietic stem cells (HSCs) and common
myeloid progenitors (CMPs), but is absent from lymphoid cellprecursors [4]. The expression of C/EBPa is maintained as CMPs
differentiate into granulocyte/macrophage progenitors (GMPs),
but it is then downregulated as CMPs differentiate into megakaryo-
cyte/erythrocyte progenitors (MEPs) [5]. C/EBPa-null mice lack
GMPs [6,7]. C/EBPa expression is low in basophil/mast cell progen-
itors (BMCPs); however, during differentiation, expression is
upregulated in basophils but is downregulated in mast cells, indi-
cating that the level of C/EBPa expression plays an important role
in basophil and mast cell lineage commitment. It has been reported
that C/EBPa, as well as GATA family transcription factors, is
involved in mast cell development in mice [8]. Although the role
of C/EBPa in human mast cells is not well known, it has been
reported that the C/EBPa expression level in human mast cells is
lower than monocytes [9], suggesting that low level expression
of C/EBPamay be also important for mast cell lineage commitment
in human.
Mast cells and basophils are both derived from HSCs. Both of
them express high afﬁnity IgE receptor (FceRI) on their surface
and play a critical role in allergic inﬂammation. In contrast, mast
cells abundantly express c-kit, but basophils do not express it.
Basophils generically differentiate in the bone marrow, and exist
as mature cells in the circulation. In contrast, mast cells are
released into the blood as immature cells and ﬁnally mature
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intestinal mucosa and dermis, to obtain tissue-speciﬁc characters
[10,11], suggesting that factors in the local environment of each
peripheral tissue affect the terminal differentiation of mast cells.
Although it has been suggested that C/EBPa plays a critical role
in mast cell and basophil lineage commitment as mentioned above,
neither the function of C/EBPa in mast cells after lineage commit-
ment nor the effect of local environmental factors on C/EBPa
expression in mast cells has not yet been determined.
One of the peripheral tissues inhabited by large numbers of
mast cells is the intestine, which has distinct environmental factors
due to the huge numbers of commensal bacteria. Since the intes-
tine is exposed to large quantities of these non-self-antigens, and
since it has a unique immune system, the characteristics of intes-
tinal mast cells may differ from those in other tissues. It has been
hypothesized that commensal bacteria may be involved in the ter-
minal differentiation of mast cells in the intestine [12].
Here, we examined the role of C/EBPa in the terminal differen-
tiation of mast cells, and showed that the expression level of
C/EBPa inﬂuences the balance between mast cell functions.
Furthermore, we showed that commensal bacteria regulate the
function of mast cells by affecting C/EBPa expression.2. Materials and methods
2.1. Mice
C57BL/6 mice and MyD88/ mice in a C57BL/6 background
were purchased from CLEA Japan (Tokyo, Japan) and Oriental Bio-
Service (Kyoto, Japan), respectively. All animal experiments were
performed in accordance with the guidelines for the care and use
of laboratory animals of Nihon University.
2.2. Cell culture
Mouse bone marrow-derived mast cells (BMMCs) were gener-
ated as follows. Bone marrow cells were prepared from the femurs
of 6–8-week-old female C57BL/6 mice and cultured in RPMI med-
ium supplemented with 10% FCS, 100 lg/ml streptomycin, 100 U/
ml penicillin, 2 mM glutamine, 0.1 mM non-essential amino acids,
100 lg/ml sodium pyruvate, 5  105 M 2-mercaptoethanol, and
5 ng/ml recombinant murine IL-3 (Pepro tech, Rocky Hill, NJ, USA).
The ecotropic retrovirus packaging cell line Plat-E, which was
kind gift from Dr. Toshio Kitamura (Tokyo University, Japan), was
maintained in DMEM supplemented with 10% FCS, 100 lg/ml
streptomycin, 100 U/ml penicillin, and 2 mM glutamine.
2.3. Flow cytometry
To evaluate FceRI and c-kit expression on the cell surface,
BMMCswere stainedwith Alexa-labeled IgE (clone IgE-3; BDBiosci-
ence, San Jose, CA, USA) and PE-Cy7-conjugated anti-mouse c-kit Ab
(clone 2B8; eBioscience), or PE-conjugated anti-mouse FceRIa Ab
(clone MAR-1; eBioscience) and FITC-conjugated anti-mouse c-kit
Ab (clone 2B8; eBioscience) at 4 C for 30 min. These stained cells
were then analyzed by FACSCanto or FACSCalibur (BectonDickinson
Biosciences, San Jose, CA, USA). For sorting, BMMCs were stained
with PE-conjugated anti-mouse FceRIa Ab and FITC-conjugated
anti-mouse c-kit Ab on day 21, and then FceRIa+c-kit+ population
was sorted by JSAN (Bay bioscience, Kobe, Japan).
2.4. Quantitative RT-PCR
Total RNA was prepared from BMMCs using the High Pure RNA
isolation kit (Roche, Basel, Switzerland) or the RNeasy Micro kit(QIAGEN, Hilden, Germany), and cDNA was then synthesized using
SuperScript II reverse transcriptase (Invitrogen, Carlsbad, CA, USA)
or the ReverTra Ace qPCR RT kit (TOYOBO, Osaka, Japan).
Messenger RNA expression was quantiﬁed by real-time PCR with
a LightCycler 480 (Roche) using SYBR Green I Master reagent
(Roche). The following oligonucleotide pairs were synthesized for
PCR primers: C/EBPa forward, 50-GCCAAACAACGCAACGTGGAG-30,
reverse, 50-AAGGAGCTCTCAGGCAGCTG-30, MIP-2 forward, 50-GAA
GCCCCCCTGGTTCAG-30, reverse, 50-GGTCAGTTAGCCTTGCCTTTG T-
30, GAPDH forward, 50-TGAACGGGAAGCTCACTGG-30, reverse, 50-
TCCACCACCCTGTTGCTGTA-30. Alternatively, qPCR was performed
by a Step-One Real-Time PCR system using TaqMan Fast Advanced
Master Mix (Applied Biosystems, Foster City, CA, USA). The follow-
ing Taqman probes were purchased from Applied Biosystems.
C/EBPa, Mm00514283; mast cell protease-1, Mm00656886;
mast cell protease-2, Mm00484932; mast cell protease-4,
Mm00487636; GAPDH, TaqMan Rodent GAPDH Control Reagents.
2.5. Western blotting
BMMCs were washed with ice-cold PBS and incubated on ice for
30 min in the lysis buffer (20 mM Tris pH 7.6, 1% Nonidet P-40, 1
protease inhibitor cocktail (Thermo Fisher Scientiﬁc, Hudson, NH,
USA)). Proteins were separated by SDS–PAGE and then transferred
to polyvinylidene diﬂuoride membranes for immunoblotting. Anti-
bodies to the following proteins were used as primary antibodies:
C/EBPa (Santa Cruz Biotechnology, clone 14AA, Dallas, Texas, USA),
b-actin (Santa Cruz Biotechnology). Horseradish peroxidase-linked
anti-rabbit IgG Ab (Cell Signaling Technology, Beverly, Mass., USA)
was used as secondary antibody.
2.6. Knockdown of C/EBPa expression by siRNA
C/EBPa siRNA (MSS273623) and control siRNA (12935-400)
were purchased from Invitrogen. The siRNAs were transduced
into cells by electroporation using a Neon transfection system
(Invitrogen) set at program #5.
2.7. Degranulation assay
The degranulation response was evaluated by measuring b-hex-
osaminidase release as previously described [13]. Brieﬂy, IgE-sen-
sitized BMMCs were stimulated with or without 3 ng/ml TNP-
BSA (LSL, Tokyo, Japan) at 37 C for 30 min. Whole cell lysates of
these BMMCs mixed with 1% Triton X-100 were used to quantify
total b-hexosaminidase activity. The supernatant was incubated
with 2.67 mM p-nitrophenyl-N-acetyl-b-D-glucosaminide (Nacalai
Tesque, Kyoto, Japan) for 40 min at 37 C. The reaction was stopped
by adding 0.2 M glycine (pH 11), and then the absorbance was
measured at 450 nm. b-Hexosaminidase release was expressed as
a percentage of the total b-hexosaminidase content.
2.8. Plasmid construction and transfection
Total RNA prepared from the mouse macrophage cell line
RAW264.7 (DS Pharma Biomedical, Osaka, Japan) was reverse
transcribed and ampliﬁed. The following oligonucleotide primers
were used for the PCR ampliﬁcation: forward, 50-CCCATGGA
GTCGGCCGACTTCTACG-30 and reverse, 50-CCTCACGCGCAGTTGCC
CATGGCCTT-30. The ampliﬁed product was cloned into the
pCR2.1 vector (Invitrogen) to conﬁrm the nucleotide sequence.
For inducible expression, the obtained C/EBPa cDNA was then
inserted into the tet-Advanced vector (Clonetech, Mountain View,
CA, USA) under a tet-inducible promoter. The fragment was
digested with BglII and AgeI, and then inserted into the MCS of
pMX-puro. The constructed plasmid was introduced into Plat-E
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Fig. 1. The mRNA expression of C/EBPa is markedly suppressed during the differentiation of bone marrow-derived mast cells (BMMCs). (a) The percentage of FceRI+c-kit+
cells on day 21 and day 35 was determined by ﬂow cytometric analysis. Data are shown by the representative plot and mean percentage ± S.D. of 3 independent experiments.
(b) Cell surface expression levels of FceRI in the FceRI+c-kit+ population. The data are representative histogram (shadowed area, day 21; thin line, day 35) and mean ± S.D. of
MFI values of 3 independent experiments. The asterisk indicates signiﬁcant difference (⁄P < 0.005). (c) Total RNA was prepared from FceRI+c-kit+ population on days 21 and
differentiated BMMC on day 35, reverse transcribed, and subjected to qPCR to measure C/EBPa mRNA expression. Relative values normalized to GAPDH mRNA levels are
shown. (d) Western blot analysis for the lysates of BMMCs on day 21, 28, and 35 with anti-C/EBPa and anti-b-actin Abs. Data are representative of 3 independent
experiments.
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nant retroviruses. Bone marrow cells on day 10–12 were infected
with the retroviruses for 48 h in the presence of 10 lg/ml polyb-
rene (Sigma–Aldrich, St. Louis, MO, USA), and then selected by
growth in 1 lg/ml puromycin for 1 week. Then, the puromycin-
resistant cells were expanded for several weeks. To induce gene
expression in these BMMCs, the cells were cultured in the presence
of 1 lg/ml doxycycline (DOX) for 48 h.
For transfection of differentiated BMMCs by electroporation, the
C/EBPa cDNA was inserted into pCR3.1 vector (Invitrogen). The
constructed plasmid, pCR3.1-C/EBPa, and the control vector,
pCR3.1-empty, were introduced into BMMCs by electroporation
using a Neon transfection system (Invitrogen) set at program #5.
2.9. Granule formation
BMMCs were ﬁxed with 4% paraformaldehyde at room temper-
ature for 30 min and then stained with 0.05% toluidine blue (pH
4.0). Mast cells contain granules composed of heparin andhistamine which show metachromatic red–purple stain. The
images of these stained cells were digitalized using OLYMPUS
BX60 and then quantiﬁed using Photoshop ver.10.0.1 to calculate
the number of pixels in the metachromatically stained areas
(red–purple). The sum of the metachromatically stained pixels
was divided by the total cell number for normalization.
2.10. Preparation of bacterial components
Lactobacillus casei JCM1134T (LC) (obtained from Japan Collec-
tion of Microorganisms at the RIKEN Bioresource Center, Saitama,
Japan) and Bacteroides acidifaciens type A43 (BA) (isolated from
mouse feces) were cultured in MRS broth and Eggerth–Gagnon
broth, respectively, at 37 C under anaerobic conditions. After
washing, LC and BA cells were heated at 121 C for 15 min and then
freeze dried. Alternatively, to prepare sonicated LC, washed LC cells
were ultrasonically disrupted with the aid of a Branson Soniﬁer
450 (Branson, Dabury, conn., USA) for 15 min and then freeze
dried.
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assessed by quantitative RT-PCR. The expression of each mRNA was evaluated relative to that of GAPDH by calculating the cycle threshold values. Data are shown as the
mean ± S.D. of 2 independent experiments. (b) The mRNA levels of MCPT-1, -2, and -4 were assessed by quantitative RT-PCR. The expression of each mRNA was evaluated
relative to that of GAPDH by calculating the cycle threshold values. Data are shown as the mean ± S.D. of 3 independent experiments. Asterisks indicate signiﬁcant differences
(⁄P < 0.05; ⁄⁄P < 0.005). (c) C/EBPa siRNA-transduced BMMCs were sensitized with IgE and then stimulated with antigen to induce degranulation. The degranulation rate was
determined by measuring the amount of b-hexosaminidase released relative to the total intracellular b-hexosaminidase content which was determined by lysing the cells
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production
Transfected BMMCs were cultured in the presence or absence of
1 lg/ml DOX for 48 h. These BMMCs were then stimulated with
1  108 heat-killed Escherichia coli, BA, and Listeria monocytogenes
(InvivoGen, San Diego, CA, USA) for 18 h at 2  106 cells/well. The
culture supernatant was concentrated using an ultraﬁltration col-
umn (3 K) (Millipore, Billerica, MA, USA), and then the concentra-
tion of MIP-2 was quantiﬁed using an immunoassay kit (R&B
Systems, Minneapolis, MN, USA) according to the manufacturer’sinstructions. This value was then used to calculate the original con-
centration of MIP-2 in the culture supernatant before concentra-
tion. Alternatively, 48 h after transfection with pCR3.1-C/EBPa
plasmid or pCR3.1-empty plasmid, BMMCs were stimulated with
0.01–1 lg/ml LPS (Sigma) for 4 h. The mRNA expression of MIP-2
was measured by quantitative RT-PCR as described above.
2.12. Statistical analysis
Statistical analysis was performed with the two-tailed Student’s
t-test.
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mRNA expression was assessed by quantitative RT-PCR. Data are shown as the mean ± S.D. of 5 independent experiments. Asterisks indicate signiﬁcant differences (⁄P < 0.05;
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data are representative of 2 or 3 independent experiments. (c) Control or C/EBPa expression cassette-transduced BMMCs were treated with DOX for 48 h. Granule formation
in control (top) or C/EBPa-transduced (bottom) BMMCs was determined by toluidine blue staining. Data are representative microscopic images from 2 independent
experiments. (d) Empty or C/EBPa expression plasmid was transduced into BMMCs. After 48 h, the mRNA levels of Mcpt-1, -2, and -4 were assessed by quantitative RT-PCR.
The expression of each mRNA was evaluated relative to that of GAPDH by calculating the cycle threshold values. Data are shown as the mean ± S.D. of 3 independent
experiments. Asterisks indicate signiﬁcant differences (⁄P < 0.05). (e) Control or C/EBPa expression cassette-transduced BMMCs were treated with DOX for 48 h. Then, the
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released relative to the total intracellular b-hexosaminidase content. The results are expressed as the mean ± S.D. of 2 independent experiments.
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3.1. C/EBPa expression decreases during differentiation of BMMC
Culturing bone marrow cells of mice with IL-3 for more than
4 weeks is known to yield an almost 100% pure population of mast
cells [14]. We ﬁrst analyzed the expression of the mast cell markers
FceRI and c-kit in these cultures by ﬂow cytometry. Three weeks
after starting the culture (on day 21), 32.2% ± 3.25% of the total cell
population was FceRI+c-kit+. After culturing for an additional
2 weeks (on day 35), the percentage reached 96.3 ± 1.89%
(Fig. 1a), indicating that the percentage of mast cells was increasedby selective survival of mast cells with IL-3. Furthermore, the FceRI
expression level in the FceRI+c-kit+ population was higher on day
35 than on day 21 (Fig. 1b), showing that the maturation of mast
cells was promoted in this period. We used this in vitro differenti-
ation system to measure the changes in C/EBPa expression. It has
been reported that C/EBPa expression is downregulated in mast
cells depending on their maturation stage [15]. To examine the
change in C/EBPa expression in mast cell population, FceRI+c-kit+
cells were sorted on day 21. C/EBPa mRNA expression level was
much lower in BMMCs on day 35 (FceRI+c-kit+ >95%) than in the
sorted population on day 21 (Fig. 1c). We further conﬁrmed that
the expression of C/EBPa protein markedly decreased during day
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(Fig. 1d). The decrease in C/EBPa expression was thought to be
dependent both on the maturation of the mast cell population
and on the decrease in cells that are different from mast cells
and express C/EBPa at a high level.
3.2. C/EBPa suppresses granule formation in mast cells
We next tried to clarify the role of C/EBPa in mast cells by
knockdown and overexpression experiments. In the knockdown
experiment, siRNA against C/EBPa was introduced into differenti-
ated BMMCs on days 35–45. Forty-eight hours after introduction
of the siRNA, the C/EBPa mRNA expression level decreased to
approximately 10% of the control level (Fig. 2a). In contrast, the
mRNA expression of mast cell protease (Mcpt)-1 and Mcpt-2 was
signiﬁcantly increased following C/EBPa knockdown (Fig. 2b).
Because Mcpt-1 and Mcpt-2 are located in granules, this suggested
that C/EBPa may be involved in the regulation of granule forma-
tion. Furthermore, we analyzed the effect of C/EBPa knockdown
on degranulation following IgE/antigen stimulation. The degranu-
lation rates in C/EBPa siRNA-transduced cells did not differ from
the control cells (Fig. 2c). Under this condition, the percentage of
the FceRI+c-kit+ cell population and the level of FceRI and c-kit
expression were not altered (Fig. 2d).
For the C/EBPa overexpression experiment, we used a tetracy-
cline-inducible retrovirus expression system that makes it possible
to control the timing of gene expression. C/EBPa expression was
induced in differentiated BMMCs (day 49 to day 56) by adding
DOX to avoid the effects of C/EBPa overexpression on the early dif-
ferentiation of mast cells. We conﬁrmed that the mRNA expression
of C/EBPa was higher in cells transfected with the C/EBPa
expression cassette than in control cells and that expression was
increased by the addition of DOX only in C/EBPa-transduced
cells (Fig. 3a). Since the expression level of C/EBPa was higher in
C/EBPa-transduced cells than in control cells even in the absence
of DOX, there was likely some leaky induction of C/EBPa
expression in the absence of DOX.Because it has been reported that mast cell progenitors enforced
with C/EBPa expression are reprogrammed into basophils [15], we
examined whether overexpression of C/EBPa affected lineage com-
mitment in our system by measuring the surface expression of
FceRI and c-kit. No difference was observed in the cell surface
expression of FceRI and c-kit between C/EBPa-transduced cells
and control cells nor between DOX-treated and untreated cells,
and the percentage of FceRI+c-kit+ cells was greater than 95% in
all samples (Fig. 3b). These data indicate that the BMMCs did not
differentiate into basophils or other cell types when C/EBPa
expression was induced during the late stages of differentiation,
suggesting that lineage commitment between mast cells and baso-
phils was determined at an earlier stage. In addition, the leaky
induction of C/EBPa expression in the absence of DOX also did
not affect the differentiation into mast cells, indicating that this
level of C/EBPa expression in bone marrow cells cultured for 10–
12 days in the presence of IL-3 dose not facilitate the differentia-
tion into basophils. Therefore, it should be possible to clarify the
role of C/EBPa in the terminal differentiation of mast cells using
this experimental system.
Since the knockdown experiments suggested that C/EBPa is
involved in the regulation of granule formation, we next deter-
mined the effect of C/EBPa overexpression on granule formation
in BMMCs. C/EBPa-transduced cells showed weak metachromatic
staining with toluidine blue compared with that of the control cells
in the presence of DOX (Fig. 3c), indicating that granule formation
was suppressed by the overexpression of C/EBPa. In addition, we
tested the effect of C/EBPa overexpression on Mcpt-1, 2, and 4
expression. The overexpression of C/EBPa in differentiated BMMCs
suppressed the expression of Mcpts (Fig. 3d). We further analyzed
degranulation upon IgE/antigen stimulation using the C/EBPa over-
expression system. Consistent with the results from the knockdown
experiment, the degranulation rates in the C/EBPa-transduced cells
did not differ from the control cells in the presence of DOX (Fig. 3e).
These results indicate that although the degranulation rate, i.e.,
the ratio of granule content released to total granule content, is
not decreased, C/EBPa inhibits granule formation and thereby
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stimulation, which may suppress the allergic reaction of mast cells.
Recently, it was reported that C/EBPa represses mast cell molecu-
lar programing by directly inhibiting MITF expression [16].
Because MITF is involved in expression of granule molecules such
as Mcpt-1, 2, we examined the mRNA expression of MITF. On our
experimental condition, MITF expression was not affected by the
ﬂuctuating C/EBPa expression. These results suggest that the
change in Mcpt-1, 2 expression by C/EBPa-knockdown or
overexpression resulted from the direct effect of C/EBPa but not
indirect effect through inhibition of MITF expression. Indeed,
several C/EBP binding motifs exist in Mcpt-1, 2 gene promoter
regions. Furthermore, it has been reported that C/EBPb, a member
of the C/EBP family binds to Mcpt-2 promoter region and repressesMcpt-2 promoter activity [17]. In addition, the percentage of the
FceRI+c-kit+ cell population and the level of FceRI and c-kit expres-
sion were not altered by C/EBPa-knockdown or overexpression in
our experiments, while Xi et al. indicated that basophils converted
into mast cells under C/EBPa knockdown condition using C/EBPa
conditional knockout mice [16]. Moreover, bone marrow cells from
MITF mutant mice yielded low percentage of the FceRI+c-kit+ cells
when cultured in the presence of IL-3 [16].
3.3. C/EBPa increases MIP-2 production from mast cells
Recently, mast cells, which are strategically located at the host-
environment interface, have been attracting increased attention as
innate immune cells as well as effector cells of allergic reactions.
4652 K. Kasakura et al. / FEBS Letters 588 (2014) 4645–4653Mast cells express TLRs, pattern recognition receptors for microbial
components, and activation of mast cells through TLRs induces the
de novo synthesis and secretion of cytokines and chemokines [18–
21]. It has been reported that mast cell-deﬁcient mice, W/Wv, are
less efﬁcient at clearing pathogenic bacteria in cecal ligation and
puncture (CLP)-induced peritonitis. Moreover, TLR4 expression
on mast cells is required for protection from CLP-induced acute
bacterial infection in mice [22,23]. Because C/EBPa is critical for
the differentiation of macrophages, which are also well-known
innate immune cells, it is possible that C/EBPa in mast cells pro-
motes their innate immune functions. To test this hypothesis, we
examined chemokine production from C/EBPa-transduced or con-
trol BMMCs following bacterial stimulation in the presence of DOX.
MIP-2 production was increased by C/EBPa overexpression
(Fig. 4a). C/EBPa-overexpressing cells secreted MIP-2 in response
to gram-negative bacteria such as B. acidifaciens and E. coli,
whereas they did not secrete MIP-2 in response to the gram-posi-
tive bacterium L. monocytogenes. We further examined MIP-2
induction upon stimulation with LPS in C/EBPa-overexpressing
BMMCs. Upregulation of MIP-2 mRNA by LPS was signiﬁcantly
higher in C/EBPa-overexpressing cells was than in control cells
(P < 0.05, Fig. 4b). These results suggest that BMMCs overexpress-
ing C/EBPa are more sensitive to gram-negative bacteria due to
enhanced signal transduction through TLR4, perhaps by regulating
the expression of signaling molecules. Alternatively, C/EBPa may
directly bind to the MIP-2 promoter and enhance MIP-2 transcrip-
tion, as there are several C/EBP binding motifs in the mouse MIP-2
promoter region. It has been reported that KC/CXCL1 is involved in
mast cell-dependent neutrophil recruitment and bacterial clear-
ance in CLP-induced acute bacterial infection [24–26]. KC and
MIP-2 are both members of the CXC subfamily of chemokines,
and they share 63% amino acid identity. This suggested that, like
KC, MIP-2 production frommast cells is involved in host protection
against bacterial infection. Although mast cells can also directly kill
bacteria by phagocytosis like neutrophils [27], there seems to be no
relation between the phagocytic activity and the C/EBPa expres-
sion in mast cells at present.
Collectively, these results indicate that C/EBPa, even at low
expression levels, is important for some functions of differentiated
mast cells after lineage commitment.
3.4. C/EBPa expression in mast cells is increased by stimulation with LC
Finally, we found that intestinal bacteria modulate C/EBPa
expression in mast cells. The intestine is a complex ecosystem
inhabited by 1013–1014 microorganisms that play an important
role in host health. In addition, some microorganisms promote
the differentiation of immune cells, such as Treg [28,29] and
Th17 [30] cells, in an intestine-speciﬁc manner. Therefore, we
hypothesized that some commensal microorganisms could regu-
late C/EBPa expression in mast cells. To test this possibility,
BMMCs were stimulated with sonicated L. casei JCM1134T (LC) dur-
ing late differentiation (from day 21 to day 35) (Fig. 5a). The
expression of C/EBPa was signiﬁcantly higher in cells stimulated
with LC than in unstimulated cells on day 35 (P < 0.05, Fig. 5b).
No increase in C/EBPa expression was observed in the BMMCs of
MyD88/mice, indicating that the effect of LC was MyD88-depen-
dent (Fig. 5b). Under these conditions, the percentage of the
FceRI+c-kit+ cell population and the level of FceRI and c-kit
expression were not altered by stimulation with LC, indicating that
bacterial stimulation did not affect lineage commitment or the
expression levels of FceRI and c-kit (Fig. 5c). Because, Lactobacillus
is the dominant genera of the commensal intestinal bacteria in
mice, this result indicates that the function of intestinal mast cells
is partially regulated by commensal bacteria through the increase
in C/EBPa expression. We previously showed that the syntheticTLR2 ligand Pam3CSK4 directly suppresses the allergic reactions
of differentiated mast cells [13], suggesting that commensal bacte-
ria regulate the allergic function of mast cells by affecting both
differentiating and differentiated mast cells. Moreover, this
result also suggests that the infection protection function of mast
cells is enhanced by stimulation with Lactobacillus through the
increased C/EBPa expression.
4. Conclusion
In conclusion, these results indicate that C/EBPa modulates the
balance between the allergic reaction and the innate immune
response of mast cells. In addition, C/EBPa expression was
increased by stimulation with LC, which suggests that commensal
bacteria modulate the function of intestinal mast cells.
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